Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milnacipran in Pain Due to Osteoarthritis
NCT01329406Phase 4Unknown
- Sponsor
- Analgesic Solutions
- Start
- Jul 2011
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in osteoarthritis (OA) comparing Milnacipran with Placebo (2 arms). Primary endpoint: Time to loss of efficacy in the Double-Blind Period at 28 days. Status: unknown.
02
Drugs
milnacipran
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01329406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01329406.